Your browser doesn't support javascript.
loading
Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom.
Brunetti, Vanessa C; St-Jean, Audray; Dell'Aniello, Sophie; Fisher, Anat; Yu, Oriana H Y; Bugden, Shawn C; Daigle, Jean-Marc; Hu, Nianping; Alessi-Severini, Silvia; Shah, Baiju R; Ronksley, Paul E; Lix, Lisa M; Ernst, Pierre; Filion, Kristian B.
Afiliação
  • Brunetti VC; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
  • St-Jean A; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, 3755 Côte Ste Catherine, Suite H410.1, Montreal, Quebec, H3T 1E2, Canada.
  • Dell'Aniello S; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, 3755 Côte Ste Catherine, Suite H410.1, Montreal, Quebec, H3T 1E2, Canada.
  • Fisher A; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, 3755 Côte Ste Catherine, Suite H410.1, Montreal, Quebec, H3T 1E2, Canada.
  • Yu OHY; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Bugden SC; Center for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, 3755 Côte Ste Catherine, Suite H410.1, Montreal, Quebec, H3T 1E2, Canada.
  • Daigle JM; Division of Endocrinology, Department of Medicine, Jewish General Hospital, Quebec, Montreal, Canada.
  • Hu N; College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Alessi-Severini S; School of Pharmacy, Memorial University of Newfoundland, St John's, Newfoundland and Labrador, Canada.
  • Shah BR; Institut national d'excellence en santé et en services sociaux (INESSS), Quebec, Quebec, Canada.
  • Ronksley PE; The Health Quality Council, Saskatoon, Saskatchewan, Canada.
  • Lix LM; College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Ernst P; Manitoba Centre for Health Policy, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Filion KB; ICES, Toronto, Ontario, Canada.
BMC Endocr Disord ; 22(1): 241, 2022 Sep 29.
Article em En | MEDLINE | ID: mdl-36175881
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simportadores / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: BMC Endocr Disord Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Simportadores / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do norte / Europa Idioma: En Revista: BMC Endocr Disord Ano de publicação: 2022 Tipo de documento: Article